Found: 6
Select item for more details and to access through your institution.
The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7181
- By:
- Publication type:
- Article
Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 1, p. 93, doi. 10.1007/s10549-022-06770-6
- By:
- Publication type:
- Article
Acute-on-chronic liver failure following eribulin treatment for metastatic breast cancer: a case report.
- Published in:
- Journal of International Medical Research, 2022, v. 50, n. 7, p. 1, doi. 10.1177/03000605221090097
- By:
- Publication type:
- Article
Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.
- Published in:
- Oncogenesis, 2018, v. 7, n. 8, p. 1, doi. 10.1038/s41389-018-0069-z
- By:
- Publication type:
- Article
The association between Notch4 expression, and clinicopathological characteristics and clinical outcomes in patients with breast cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 8749, doi. 10.3892/ol.2018.8442
- By:
- Publication type:
- Article
Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135851
- By:
- Publication type:
- Article